FDC Limited

FDC Limited (FDC) is a small-cap Healthcare company valued at ₹5,807 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

FDC Limited last traded at ₹353.8, modestly up 1.51% on the day.

Recent developments

On 2026-02-11, the company announced a dividend of ₹5.00 per share, ex-date. Promoter holding remained at 69.66% as of 2026-06-30. Foreign institutional holding decreased by 1.00 percentage points to 1.40% in the quarter.

Financial performance

The company's annual revenue grew 3.0% to ₹2,171 crore, while annual net profit rose 5.4% to ₹281 crore. In the latest quarter, revenue increased 3.0% year-over-year to ₹668 crore, and net profit rose 9.5% to ₹132 crore, showing consistent growth in both metrics.

Valuation multiples

The stock trades at 20.5 times earnings, a discount to the Healthcare median of 32.0, 2.26 times book value. It yields 1.4%.

Things to watch

The stock is 29.5% below its 52-week high. Net profit margin increased slightly to 13.0% from 12.7% but remains below the 5-year average. The company's 5-year profit CAGR is negative at -1.3% per year, indicating declining profitability over the past five years.

Where it stands

FDC has shown steady revenue and profit growth in the latest quarter and over the past year, with a net profit margin improving slightly. However, the stock is significantly below its 52-week high, and the 5-year profit CAGR is negative. The company remains almost debt-free with a debt-to-equity ratio of 0.00.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.